Worldwide Cancer is a leading cause of death. In the year 2020, approximately 10 million deaths, or nearly one in six deaths were because of cancer.
Now in revolutionary medical research, scientists discovered a new molecule that kills even the deadliest cancer. In a small clinical trial by doctors at New York’s Memorial Sloan Kettering Cancer Center (MSK), the patients took a drug called dostarlimab for six months. All of them saw their tumors disappear at the end of the trial.
Medical oncologist and the senior author of a new paper, Luis Diaz Jr. from MSK, said, “I believe this is the first time this has happened in the history of cancer,”
But until now, the trial was done on just 12 rectal cancer patients. To treat their cancer, the patients had undergone treatments like chemotherapy, radiation, and invasive surgery.
In all patients, the tumors had not advanced to other organs. But in all cases, it was spread within the rectum and in some cases, to the lymph nodes. At the end of six months, patients underwent a series of medical exams such as physical exam, endoscopy, positron emission tomography or PET scans, or MRI scans.
Although the findings concerning dostarlimab are very encouraging, there is a need for long-term studies to understand the real impact.